Revolution Medicines (RVMD) USD0.0001

Sell:$36.54Buy:$36.63$0.09 (0.23%)

NASDAQ:0.09%
Prices delayed by at least 15 minutes
Sell:$36.54
Buy:$36.63
Change:$0.09 (0.23%)
Prices delayed by at least 15 minutes
Sell:$36.54
Buy:$36.63
Change:$0.09 (0.23%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 June 2025
Jeff CisliniCompany Secretary
Sell
Option/Award related
1,912$39.61$75,735.8554,093
16 June 2025
Mark A GoldsmithChairman/CEO
Sell
Tax related
13,496$39.83$537,545.68428,720
16 June 2025
Stephen Michael KelseyOther President
Sell
Tax related
4,289$39.83$170,830.87289,414
16 June 2025
Margaret A (Peg) HornCOO
Sell
Tax related
3,510$39.83$139,803.30150,675
16 June 2025
Jack Lee AndersCFO
Sell
Tax related
2,170$39.83$86,431.10113,314
16 June 2025
Lin WeiChief Level Officer
Sell
Tax related
2,173$39.83$86,550.5990,499
16 June 2025
Jeff CisliniCompany Secretary
Sell
Tax related
1,878$39.83$74,800.7456,005
20 March 2025
Jeff CisliniCompany Secretary
Sell
Option/Award related
2,041$38.71$79,008.1357,723
17 March 2025
Mark A GoldsmithChairman/CEO
Sell
Tax related
11,738$39.04$458,255.04441,564
17 March 2025
Stephen Michael KelseyOther President
Sell
Tax related
3,294$39.04$128,598.75293,051

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 December 2024
NEXTECH INVEST AGVenture Capital
Buy
Regular purchase transaction
760,869$46.00$34,999,974.00760,869
5 December 2024
NEXTECH INVEST AGVenture Capital
Buy
Regular purchase transaction
543,478$46.00$24,999,988.002,096,612
4 November 2024
Mark A GoldsmithChairman/CEO
Sell
Option/Award related
50,900$55.56$2,827,820.76300,170
11 October 2024
Margaret A (Peg) HornCOO
Sell
Option/Award related
50,000$50.34$2,517,055.00132,320
11 October 2024
Mark A GoldsmithChairman/CEO
Sell
Option/Award related
30,000$50.36$1,510,773.00300,170

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.